ZURICH, SWITZERLAND  / February 8, 2023 / Nanoflex Robotics AG, a pioneer in magnetically controlled medical soft robotics, today announced that it has achieved an initial $12 million in funding. Nanoflex Robotics will use the funding to bring its first-generation system to market and to accelerate development of new neuro-interventional products. A first-in-human trial and FDA submission is planned for Q3 2023.

Nanoflex Robotics is a spin out from ETHZ developing endoluminal soft robotic systems that can be remotely manipulated within the body. We're focused on Interventional Neuro Radiology procedures for the access to and treatment of Ischemic and Hemorrhagic stroke.  

Swiss Robotic Endovascular Navigation Platform Secures Over Usd12M In Funding Support

Description

Company Information

Related People

Funding Insights